|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/00 | |
| A61K 47/10 | |||
| A61K 9/10 | |||
| A61K 9/14 | |||
| C07D 491/107 | |||
| A61K 31/517 | |||
| A61P 35/00 | |||
| A61P 27/02 |
| (11) | Number of the document | 3062618 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14857737.2 |
| Date of filing the European patent application | 2014-10-31 | |
| (97) | Date of publication of the European application | 2016-09-07 |
| (45) | Date of publication and mention of the grant of the patent | 2020-02-05 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/063444 |
| Date | 2014-10-31 |
| (87) | Number | WO 2015/066482 |
| Date | 2015-05-07 |
| (30) | Number | Date | Country code |
| 201361898741 P | 2013-11-01 | US | |
| 201462039177 P | 2014-08-19 | US | |
| 201462039192 P | 2014-08-19 | US |
| (72) |
ENLOW, Elizabeth, US
NGUYEN, Minh Ngoc, US
ONG, Winston Z., US
|
| (73) |
Kala Pharmaceuticals, Inc.,
490 Arsenal Way, Suite 120, Watertown, MA 02472,
US
|
| (54) | CRYSTALLINE FORMS OF THERAPEUTIC COMPOUNDS AND USES THEREOF |
| CRYSTALLINE FORMS OF THERAPEUTIC COMPOUNDS AND USES THEREOF |